The Ability of Orally Administered Lactobacillus Species to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.
Conditions
Breast Cancer
Conditions: official terms
Breast Neoplasms
Conditions: Keywords
chemotherapy, vaginal flora
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Intervention
Name: Probiotics Type: Dietary Supplement
Name: Oral lactose placebo Type: Dietary Supplement
Overall Status
Recruiting
Summary
The aim of this study is the improvement of the vaginal flora by at least two grades of the Nugent scale after application of oral probiotics.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

Only women with breast cancer and neoadjuvant / adjuvant chemotherapy, at least 4 weeks postoperative, without vaginal bleeding without abnormal vaginal discharge, Only women with Nugent scores between 4 and 6

Exclusion Criteria:

Patients with diarrhoea, constipation, vaginal or urinary tract infection requiring antibacterial treatment and women receiving antibiotic therapy in the previous 4 weeks.
Location
Medical University of Vienna - Department of Obstetrics and Gynecology
Vienna, Austria
Status: Recruiting
Contact: Julian Marschalek, MD - +431404002938 - julian.marschalek@meduniwien.ac.at
Start Date
October 2012
Completion Date
October 2015
Sponsors
Medical University of Vienna
Source
Medical University of Vienna
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page